Market revenue in 2023 | USD 1,149.6 million |
Market revenue in 2030 | USD 2,305.9 million |
Growth rate | 10.5% (CAGR from 2023 to 2030) |
Largest segment | Pap test |
Fastest growing segment | HPV Test |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pap Test, HPV Test |
Key market players worldwide | Abbott Laboratories, Qiagen NV, Becton Dickinson & Co, Quest Diagnostics Inc, Hologic Inc, Roche Holding AG ADR, Femasys Inc, Thermo Fisher Scientific Inc, BioMerieux SA, Seegene, Arbor Vita Corporation, Nurx |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hpv testing and pap test market will help companies and investors design strategic landscapes.
Pap test was the largest segment with a revenue share of 62.49% in 2023. Horizon Databook has segmented the Europe hpv testing and pap test market based on pap test, hpv test covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe hpv testing and pap test market , including forecasts for subscribers. This continent databook contains high-level insights into Europe hpv testing and pap test market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account